Jeff Huber, co-founder and general partner at Triatomic Capital, on his career path in tech, and then biotech.

Lori Lyons-Williams, CEO of Abdera Therapeutics, on developing targeted radiopharmaceuticals for cancer.

Turning the Tables, Rob Perez Interviews Me

Zach Weinberg and Alexis Borisy of Curie.Bio on Freeing the Biotech Founders

Fred Appelbaum, a physician, scientist and leader at the Fred Hutchinson Cancer Center, on 'Living Medicine,' his new book about the development of bone marrow transplantation and the rise of cell therapy.

Colin Hill, co-founder and CEO of Aitia, on digging deep into biological datasets and finding new drug targets.

Yung Lie, president and CEO of Damon Runyon Cancer Research Foundation, on advancing cancer research by supporting young scientists with bold and brave ideas.

Kevin Conroy, CEO of Exact Sciences, on early detection of cancer.

Jodie Morrison, acting CEO of Q32Bio, on becoming a biotech CEO.

Aaron Ring, a scientist at Yale moving to the Fred Hutchinson Cancer Center, on applying immunology and protein engineering for cancer therapy and more.